NYSE:CHEHealthcare
Is It Time To Reconsider Chemed (CHE) After The Past Year’s 25% Share Price Slide?
Wondering whether Chemed at around US$421 per share is offering good value or extra risk? This article walks through the key signals that can help you judge the stock for yourself.
The share price has slipped about 1.1% over the last week, after a 9.2% gain over the past month. It is still down 0.6% year to date and 25.6% over the last year, which may have some investors reassessing both the upside and the risks.
Recent coverage has focused on Chemed's position as a healthcare services stock...